DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Epigral Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 8 hrs ago·7 Aug 2026, 11:26 am

Epigral

Epigral Limited has announced its participation in the upcoming EMKAY Confluence 2026 event scheduled for August 12, 2026. This investor conference provides a platform for the company to engage with institutional investors, analysts, and potential partners. The company will likely use this opportunity to discuss its business strategy, operational performance, and future growth plans with a select audience of financial experts.

For investors, this meeting is a key opportunity to gain direct insights into management's outlook and gauge market sentiment. It highlights the company's proactive approach to investor relations and transparency. While the specific details of the discussion are not yet known, the event signals management's readiness to communicate its vision. Investors should monitor the company's future disclosures for any specific updates or guidance shared during the conference.